Benitec Biopharma Valuation
| BNTC Stock | USD 6.86 0.14 2.08% |
At this time, the firm appears to be overvalued. Benitec Biopharma shows a prevailing Real Value of $4.94 per share. The current price of the firm is $6.86. Our model approximates the value of Benitec Biopharma from analyzing the firm fundamentals such as Return On Equity of -1.78, operating margin of (355.61) %, and Shares Outstanding of 2.59 M as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor purchasing undervalued instruments and exiting overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Overvalued
Today
Please note that Benitec Biopharma's price fluctuation is very risky at this time. Calculation of the real value of Benitec Biopharma is based on 3 months time horizon. Increasing Benitec Biopharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Benitec Biopharma Ltd is useful when determining the fair value of the Benitec stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Benitec Biopharma. Since Benitec Biopharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Benitec Stock. However, Benitec Biopharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6.86 | Real 4.94 | Hype 6.86 | Naive 7.27 |
The real value of Benitec Stock, also known as its intrinsic value, is the underlying worth of Benitec Biopharma Company, which is reflected in its stock price. It is based on Benitec Biopharma's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Benitec Biopharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Benitec Biopharma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Benitec Biopharma Ltd helps investors to forecast how Benitec stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Benitec Biopharma more accurately as focusing exclusively on Benitec Biopharma's fundamentals will not take into account other important factors: Benitec Biopharma Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Benitec Biopharma's current stock value. Our valuation model uses many indicators to compare Benitec Biopharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Benitec Biopharma competition to find correlations between indicators driving Benitec Biopharma's intrinsic value. More Info.Benitec Biopharma Ltd is rated below average in price to earning category among related companies. It is rated below average in price to book category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Benitec Biopharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Benitec Biopharma's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Benitec Biopharma's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Benitec Biopharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Benitec Biopharma and how it compares across the competition.
About Benitec Biopharma Valuation
The stock valuation mechanism determines the current worth of Benitec Biopharma Ltd on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Benitec Biopharma Ltd. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Benitec Biopharma based exclusively on its fundamental and basic technical indicators. By analyzing Benitec Biopharma's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Benitec Biopharma's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Benitec Biopharma. We calculate exposure to Benitec Biopharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Benitec Biopharma's related companies.Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company was incorporated in 1995 and is headquartered in Hayward, California. Benitec Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 18 people.
8 Steps to conduct Benitec Biopharma's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Benitec Biopharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Benitec Biopharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Benitec Biopharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Benitec Biopharma's revenue streams: Identify Benitec Biopharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Benitec Biopharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Benitec Biopharma's growth potential: Evaluate Benitec Biopharma's management, business model, and growth potential.
- Determine Benitec Biopharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Benitec Biopharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Benitec Biopharma Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Benitec Biopharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.4 M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Benitec Biopharma Ltd. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Complementary Tools for Benitec Stock analysis
When running Benitec Biopharma's price analysis, check to measure Benitec Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Benitec Biopharma is operating at the current time. Most of Benitec Biopharma's value examination focuses on studying past and present price action to predict the probability of Benitec Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Benitec Biopharma's price. Additionally, you may evaluate how the addition of Benitec Biopharma to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |
Is Benitec Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Benitec Biopharma. If investors know Benitec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Benitec Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Benitec Biopharma is measured differently than its book value, which is the value of Benitec that is recorded on the company's balance sheet. Investors also form their own opinion of Benitec Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Benitec Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Benitec Biopharma's market value can be influenced by many factors that don't directly affect Benitec Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Benitec Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Benitec Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Benitec Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.